{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -1.9480501, "regularMarketPrice": 1.51, "exchange": "FRA", "shortName": "HANSOH PHARMAC. HD-,00001", "longName": "Hansoh Pharmaceutical Group Company Limited", "messageBoardId": "finmb_589660751", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683875702, "regularMarketDayHigh": 1.51, "regularMarketDayRange": "1.51 - 1.51", "regularMarketDayLow": 1.51, "regularMarketVolume": 100, "regularMarketPreviousClose": 1.54, "bid": 1.46, "ask": 1.59, "fullExchangeName": "Frankfurt", "financialCurrency": "CNY", "regularMarketOpen": 1.51, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.110000014, "fiftyTwoWeekLowChangePercent": 0.07857144, "fiftyTwoWeekRange": "1.4 - 2.16", "fiftyTwoWeekHighChange": -0.6500001, "fiftyTwoWeekHighChangePercent": -0.30092597, "fiftyTwoWeekLow": 1.4, "fiftyTwoWeekHigh": 2.16, "trailingAnnualDividendRate": 0.088, "trailingPE": 25.166668, "trailingAnnualDividendYield": 0.057142857, "epsTrailingTwelveMonths": 0.06, "sharesOutstanding": 5933349888, "bookValue": 3.826, "fiftyDayAverage": 1.6174, "fiftyDayAverageChange": -0.10740006, "fiftyDayAverageChangePercent": -0.066402905, "twoHundredDayAverage": 1.71045, "twoHundredDayAverageChange": -0.20045006, "twoHundredDayAverageChangePercent": -0.11719142, "marketCap": 9658895360, "priceToBook": 0.39466807, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1560924000000, "priceHint": 4, "regularMarketChange": -0.029999971, "symbol": "3KY.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "287 Xiangke Road", "address2": "Pudong New District", "city": "Shanghai", "zip": "201210", "country": "China", "phone": "86 40 0828 5227", "website": "https://www.hspharm.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-tumor, anti-infectives, central nervous system diseases, metabolic diseases, and other therapeutic areas. Its principal products include Mailingda, Ameile, Hansoh Xinfu, Fulaimei, Hengmu, Xinwei, Tanneng, Ameining, Oulanning, Ailanning, Zetan, Ruibote, Fulaidi, Puruian, Fulairui, Pulaile, Zefei, Xinmei, Xintai, and Gainuo drugs, as well as XINYUE and Hengsen. The company serves pharmaceutical product distributors. It has a collaborations with NiKang Therapeutics to develop and commercialize NKT2152; TiumBio to develop and commercialize TU2670 for the treatment of endometriosis, uterine fibroids and other indications; Global Health Drug Discovery Institute to develop, manufacture, and commercialize the GDI-4405 series of anti-novel coronavirus; KiOmed Pharma SA to develop and commercialize KiOmedinevsOne for the treatment of osteoarthritis; and Biotheus Inc. to develop and commercialize PM1080. The company was founded in 1995 and is headquartered in Shanghai, the People's Republic of China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.", "fullTimeEmployees": 10523, "companyOfficers": [{"maxAge": 1, "name": "Ms. Huijuan  Zhong", "age": 61, "title": "Chairlady, CEO & Pres", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Min  Hu", "age": 45, "title": "VP & CFO", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aifeng  Lyu", "age": 45, "title": "Exec. Director", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yuan  Sun", "age": 35, "title": "Exec. Director", "yearBorn": 1987, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gongzheng  Wu", "age": 51, "title": "Sr. VP", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Chunhua  Zhong", "age": 47, "title": "Sr. VP", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chuanhe  Xu", "age": 58, "title": "Sr. VP", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rudi  Bao", "age": 58, "title": "Sr. VP", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Weiyong  Sun", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Qiong  Wu", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 1, "compensationRisk": 3, "shareHolderRightsRisk": 8, "overallRisk": 1, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}